TellWell
← Misinformation tracker
UnverifiableNews · Health

Yes, Skipping the Vitamin K Shot Really Does Put Newborns at 81 Times Greater Risk

Infants without vitamin K prophylaxis face 81 times greater risk of vitamin K deficiency bleeding compared to those who receive it

The argument in brief

Some parents refuse the vitamin K shot given to newborns at birth, believing it unnecessary. The claim that this raises a baby's risk of vitamin K deficiency bleeding (VKDB) by 81 times is true — a 2014 study in Pediatrics tracked a cluster of cases in Tennessee and calculated exactly that risk ratio. Without the shot, late VKDB affects up to 7 in 100,000 births; with it, cases are virtually zero.

The numbersLate VKDB Incidence: With vs. Without Vitamin K Prophylaxis

Data: Schulte et al., Pediatrics 2014; Lippi & Franchini, Blood Transfusion 2011

Why it spread

Parents who decline the vitamin K shot often do so out of genuine concern for their newborn, influenced by online communities that frame routine newborn procedures as unnecessary medical interventions. The 81-fold statistic gets shared widely by pediatricians and public health advocates precisely because its scale is hard to ignore — it puts a concrete number on a risk that might otherwise feel abstract.

The claim is accurate. Infants who do not receive vitamin K prophylaxis at birth face roughly 81 times the risk of vitamin K deficiency bleeding compared to those who do. This is not an estimate pulled from thin air — it comes from peer-reviewed research and lines up with decades of epidemiological data.

Newborns are born with very low vitamin K levels. Their gut bacteria, which help produce the vitamin later in life, haven't developed yet, and breast milk contains little of it. Without a supplement, some infants develop VKDB — internal bleeding that can strike the brain, gut, or other organs, often with no warning. The American Academy of Pediatrics has recommended the birth shot since 1961 for exactly this reason.

The 81-fold figure comes from a 2014 study by Schulte and colleagues, published in Pediatrics, which investigated a cluster of VKDB cases in Tennessee. All affected infants had parents who declined the shot. The researchers calculated an 81-times greater risk for unvaccinated infants. The CDC's own Morbidity and Mortality Weekly Report from 2013 flagged the same Tennessee cases and reached consistent conclusions.

Broader research backs this up. A review by Lippi and Franchini in Blood Transfusion found late VKDB rates of 4.4 to 7.2 per 100,000 births without prophylaxis, versus near-zero with the intramuscular shot. A comprehensive review by Shearer in The Lancet found IM vitamin K reduces VKDB risk by over 99 percent. The math behind the 81-fold claim is solid.

The strongest objection raised by skeptics is that VKDB is rare even without the shot — and that's technically true. But rare does not mean acceptable when a single safe injection eliminates the risk almost entirely. Brain bleeds from late VKDB can cause permanent disability or death. The risk-benefit calculation is not close.

This statistic spreads because it is striking and because refusal of the vitamin K shot has grown alongside broader hesitancy toward newborn medical interventions. Watch out for claims that the shot is "toxic," contains dangerous additives, or is linked to cancer — those claims have been thoroughly investigated and rejected. The shot is safe, the risk of skipping it is real, and the 81-times figure accurately reflects what the evidence shows.

Sources

  • American Academy of Pediatrics (AAP) Policy Statement on Vitamin K

    The AAP has consistently recommended intramuscular vitamin K prophylaxis at birth, noting that without it, VKDB incidence is approximately 0.25-1.7% in early-onset cases, with late VKDB occurring in 4.4-7.2 per 100,000 births versus near-zero in prophylaxed infants.

  • Schulte et al., Pediatrics (2014) - Tennessee VKDB cases

    A cluster of VKDB cases in Tennessee among infants whose parents refused vitamin K prophylaxis demonstrated dramatically elevated risk; the study estimated an 81-fold increased risk of VKDB in infants not receiving prophylaxis compared to those who did.

  • CDC Morbidity and Mortality Weekly Report (MMWR) 2013

    CDC reported on late VKDB cases in Tennessee and noted that infants not receiving vitamin K prophylaxis had substantially elevated bleeding risk, consistent with the 81-fold risk estimate cited in subsequent literature.

  • Lippi & Franchini, Blood Transfusion (2011)

    Review confirmed that late VKDB occurs in 4.4–7.2 per 100,000 births without prophylaxis and is virtually eliminated with IM vitamin K, supporting very large relative risk reductions consistent with an ~81-fold difference.

  • Shearer, Lancet (2009) - Vitamin K deficiency bleeding review

    Comprehensive review found that intramuscular vitamin K prophylaxis reduces VKDB risk by over 99%, and that without prophylaxis, late VKDB affects approximately 1 in 14,000 to 1 in 25,000 infants, versus near-zero with IM prophylaxis.

  • Vitamin K Ad Hoc Task Force, Pediatrics (1993)

    Foundational AAP task force report established that newborns are universally vitamin K deficient at birth and that IM prophylaxis effectively eliminates classic and late VKDB, with untreated infants facing risks orders of magnitude higher.

TellWell AI

Related debunks